The objectives of the present study were to determine whether sodium-lithium countertransport contributes to predicting the probability of having hypertension and to determine whether it does so after other predictor traits have been considered. We used logistic regression to model the relation between sodium-lithium countertransport and the probability of having hypertension, estimated by the prevalence of hypertension among 172 men and 252 women, aged 47-89 years, from the Caucasian population of Rochester, Minn. When sodium-lithium countertransport was the only predictor trait considered, it made a statistically significant contribution to prediction both in men (model x 1 i <r =20.50, p<0.001) and in women (model x 2 i<u = 16.69, p<0.001). For each standard deviation increase in sodium-lithium countertransport, the expected odds of having hypertension increased 2.25 times in men (95% confidence interval [CI], 1.44-3.51) and 1.77 times in women (95% CI, 1J2-2J7). When sodium-lithium countertransport was not considered, the other traits identified as predictors were age, body mass index, and plasma apolipoprotein CO and CII squared; plasma apolipoprotein AI was an additional predictor in women but not in men. When sodium-lithium countertransport was added to models that included the other predictors, it improved prediction both in men (increase in model x 1 i m =1229, p< 0.001) and in women (increase in model x 2 idf=4.86, p<0.027). Based on these complete models, when the other predictors remained at their mean values, each standard deviation increase in sodium-lithium countertransport increased the expected odds of having hypertension 2.06 times in men (95% CI, 1.31-3.22) and 1.48 times in women (95% CI, 1.04-2.21). These results establish that sodium-lithium countertransport provides information that is helpful in predicting the probability of having hypertension and is not reflected in other identified predictor traits. (Hypertension 1992^0:841-850) KEY WORDS • sodium • lithium • hypertension, essential • logistic models • cross-sectional studies I dentification of biochemical, physiological, and structural variations that are associated with interindividual differences in blood pressure should provide clues to genetic and environmental variations that determine interindividual differences in the risk for development of essential hypertension (hypertension). Although many traits have been described as potential links between variation in genetic and environmental factors and variation in blood pressure, 1 few have been demonstrated to predict blood pressure or the development of hypertension. In most samples from the general population, variation in the traits hypothesized to be related to the development of hypertension accounted for less than 50% of interindividual variation in blood pressure.
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2 " 4 Of the few biological traits demonstrated to tions may decrease the magnitude of positive correlation between sodium-lithium countertransport and blood pressure levels, 8 cross-sectional studies have usually relied on contrasts of mean sodium-lithium countertransport between patients with established hypertension and normotensive control subjects (see Reference 12 for review). Although these studies demonstrate association of increased sodium-lithium countertransport with hypertension, they cannot estimate the probability for having hypertension, given that an individual has a particular value of sodium-lithium countertransport, because they did not include a representative sample of sodium-lithium countertransport levels from the population at large. Furthermore, most of these studies did not control for differences between hypertensive and normotensive subjects in traits known to influence sodium-lithium countertransport such as gender, body size, and plasma lipids. 1314 Thus, the differences in mean sodium-lithium countertransport reported between hypertensive and normotensive subjects may be biased. Proper assessment of the relation between sodium-lithium countertransport and hypertension requires representative sampling of the distribution of sodium-lithium countertransport and consideration of the potentially confounding effects of other traits related to hypertension.
The objectives of this cross-sectional study were to determine whether sodium-lithium countertransport makes a contribution to predicting the probability of having hypertension in the general Caucasian population and to determine whether it does so after the contributions of other traits related to hypertension have been considered. We used logistic regression analysis to model the relation between sodium-lithium countertransport and the probability of having hypertension as estimated by the prevalence of hypertension among adults aged 47-89 years who were representative of the population of Rochester, Minn.
Methods

The Sample
The sample consisted of 424 Caucasians who were grandparents in 276 three-and four-generation pedigrees that were a part of the Rochester Family Heart Study. These pedigrees were ascertained through 300 households that had two or more children enrolled in the schools of Rochester, Minn., in 1984. Between 1984 and 1988, 2,004 members of these pedigrees donated blood samples and were examined at the Mayo Clinic. The protocols for recruitment and examination of family members are described in detail in our previous publications. 8 -14 For the present study, we considered only grandparents because the prevalence of hypertension among children (0%) and parents (7%) was too low for reliable estimates of the relation between hypertension and its predictors. From the 540 grandparents available, we excluded one individual whose date of birth was not recorded; 16 individuals who were not fasting at the time of blood sampling; 52 individuals who were using estrogen, progesterone, glucocorticoids (orally or topically), insulin, oral hypoglycemics, lipidlowering medications, or cis-retinoic acid during the month before the clinic visit; 16 normotensive individuals who had causes of low blood pressure (e.g., debilitating illnesses); and 11 hypertensive individuals who had causes of secondary hypertension (e.g., renal diseases). The remaining 444 grandparents included 180 men and 264 women. When one of these groups contained two or more genetically related individuals, we selected at random only one individual to remain in the group. This procedure, which removed five individuals (two men and three women), ensured that subjects of the same gender were biologically independent. Finally, we excluded 15 individuals (six men and nine women) because they were not measured for one of the clinical or laboratory variables. After these exclusions, the sample for analysis included 172 men, aged 47-89 years, and 252 nonpregnant women, aged 47-88 years.
At the clinic visit, measurements were taken for each subject's height, body weight, and circumference at the waist and hips. In addition, three blood pressure readings were taken with a random zero sphygmomanometer (Hawksley and Sons, Ltd., West Sussex, England). Based on the mean systolic and mean diastolic blood pressures calculated from these readings and information from medical records about prior blood pressure levels and use of medications, we assigned each subject to one of the following diagnostic categories.
Normotension. These subjects had never been treated with medication for hypertension, and they had mean systolic and diastolic blood pressures less than 140 and 90 mm Hg, respectively, at the clinic visit. None were taking medications with blood pressure-lowering effects.
Hypertension. These subjects had mean systolic or diastolic blood pressures >140 or >90 mm Hg, respectively, at the clinic visit, or they had been previously diagnosed to have hypertension and were being treated with antihypertensive medications. Fifty-eight percent of these subjects were treated with antihypertensive medications (70% of men and 55% of women).
Laboratory Measurements
Blood samples, drawn at the clinic visit and anticoagulated with heparin, were kept at 4°C until processing for determination of erythrocyte lithium efflux. The maximal capacity for sodium gradient-dependent lithium efflux was determined by using methods developed by Canessa et al. 7 The technique requires loading red blood cells with lithium ions to estimate the rate of sodium-lithium countertransport as the difference between the rates of lithium efflux into media containing sodium ions and media in which sodium has been replaced by magnesium ions. Further details of the procedures to determine sodium-lithium countertransport, including data to support the conclusion that a single assay provides a reliable measure of an individual's level, are given in our previous publications. 8 -14 Plasma concentrations of total cholesterol and trigrycerides were measured by enzymatic methods using Dri-STAT reagents (Beckman Instruments, Brea, Calif.). The concentration of high density lipoprotein (HDL) cholesterol was measured in plasma supernatants after precipitation with PEG-6000 of particles containing apolipoprotein B. Plasma concentrations of apolipoproteins AI, All, B, CII, CIII, and E were measured by radioimmunoassays as previously described.
Statistical Analyses
Data were summarized by calculating separately for men and women the mean±SD of quantitative traits and the percentage of subjects in each stratum of categorical traits. Student's / test was used to assess differences in means between genders; Satterthwaite's correction of the t test was used when an F test of the ratio of variances indicated that the variances differed. The x 2 contingency test was used to assess differences in the distributions of categorical traits between genders. Differences were considered statistically significant when the probability of the test statistic (F, t, or x 2 ) was less than 0.05.
Classification of subjects as normotensive or hypertensive created a categorical variable with a binary outcome. To model the statistical dependency of this variable on sodium-lithium countertransport and other predictors, we used logistic regression. If we let Y represent the diagnostic outcome (0 denoting normotension and 1 denoting hypertension), the logistic regression model assumes that the relation between the probability of having hypertension (Y=l) and a vector of predictor traits, X, is given by
where e is the base of the natural (Naperian) logarithm (equal to 2.7183), a is the logarithm of the odds of having hypertension (see below) when X is null, and fi is the vector of partial regression coefficients that relate the values of X to the probability of having hypertension. When, as in the present study, cross-sectional data are used to fit the logistic regression model, the probability predicted is the probability of having hypertension (not of developing hypertension) and therefore is an estimate of the expected prevalence (not incidence) of hypertension in the population from which the sample was drawn.
After logistic transformation of expression, 1 the model gives the logarithm of the odds of having hypertension, that is, the probability of having hypertension (Y=l) divided by the probability of being normotensive (Y=0), as a linear function of the predictor traits:
Logarithm odds (Y=l)=a+/3X It follows that for any two sets of values of the predictor traits, X! and X 2 , the ratio of the odds of having hypertension given X 2 to the odds given X] is e raised to the power {} (X. . This odds ratio is the factor by which the odds of having hypertension is expected to change in response to specified changes in values of the predictors. We calculated odds ratios for 1 and for 2 SD increases in each predictor above their mean values, which were chosen as reference levels for the sample. When there was more than one predictor in a model, we referred to these estimates as conditional odds ratios (see Tables 3 and 4 ) because the calculations assume that the other predictors remained constant at their mean values.
To estimate the parameters a and p in the logistic regression model, we used the maximum likelihood principle. The values of a and /3 that maximized the likelihood of the model were obtained using the SAS LOGIST procedure described by Harrell. 16 Because as many models are possible as there are combinations of predictor traits, we describe below our statistical strategy for comparison of models and the procedure for selection of models that were compared.
Comparison of the maximum value of the likelihood of a model that included one or more predictor traits (complete model) to the maximum of the likelihood of a model without these predictors (reduced model) provides the basis for a statistical test of whether the added variable (or variables) improves the ability to predict the probability of having hypertension. Under the null hypothesis that all regression coefficients for the added variables are zero, minus two times the logarithm of the ratio of the maximum likelihoods of the complete and reduced models is distributed as a ^-2 with degrees of freedom equal to the number of added variables. When this statistic had a probability less than 0.05, we rejected the null hypothesis and concluded that the added variables made a statistically significant contribution to predicting the probability of having hypertension. When the maximum likelihood of a model with predictor traits was compared with that of an interceptonly model in which the probability of having hypertension is assumed to be constant across the ranges of the predictors and equal to the overall prevalence of hypertension, we refer to the x 2 statistic as the model x • For each regression coefficient in a model, we also calculated the Wald statistic by dividing the estimate of the coefficient by its standard error and squaring the result. Under the assumption that the estimators are asymptotically normally distributed, the Wald statistic provides a one degree of freedom test of the null hypothesis that the regression coefficient is zero. Wald statistics and their associated probability values are given for the regression coefficients in the models presented in Tables 3 and 4 . Except for the stepwise variable selection procedure described below (and presented in Table 3 ), we relied on likelihood ratio tests, not on Wald statistics, to judge whether addition of variables improved the prediction of diagnostic outcome. For models that included more than one predictor (see Tables 3 and 4) , the Wald statistics provide an indication of the statistical significance of each predictor were it the last predictor added to the model.
In each gender, analysis of the relation between diagnostic outcome and the predictors proceeded in four stages. First, to evaluate whether sodium-lithium countertransport by itself made a contribution to the prediction of hypertension, we entered the quantitative level of sodium-lithium countertransport as the only predictor in the model. The maximum value of the likelihood of this model was compared with that of the intercept-only model. We then assessed whether subsequent entry of an additional term representing secondorder effects of sodium-lithium countertransport (that is, sodium-lithium countertransport squared) further improved prediction.
Second, we used a forward stepwise selection procedure 16 to identify a parsimonious subset of traits other than sodium-lithium countertransport that were statistically significant predictors of the probability of having hypertension. Traits considered at this stage were age, height, weight, body mass index (weight divided by height squared), and waist-to-hip ratio; plasma concen-trations of total cholesterol, HDL cholesterol, triglycerides, and apolipoproteins AI, All, B, CII, CIII, and E; pulse rate; and cigarette smoking (recorded as never, former, or current). Initially we allowed only the firstorder effects to enter the model. At each step of the selection procedure, the maximum significance level for inclusion and the minimum significance for exclusion of a trait from the model was 0.05. After identifying a set of traits that were statistically significant predictors, we assessed whether addition of pairwise interactions or, subsequently, whether addition of second-order effects of these traits further improved the prediction.
Third, to assess whether sodium-lithium countertransport contributed to prediction after considering effects of the other identified predictors, we added sodium-lithium countertransport to the model built in the second step above that included the most parsimonious subset of other predictors. We then considered whether entry of additional terms representing pairwise interactions of the effects of sodium-lithium countertransport with each other predictor or, subsequently, whether addition of second-order effects of sodiumlithium countertransport contributed further to predicting the probability of having hypertension.
Fourth, we evaluated the goodness-of-fit of the models built at each stage, and we assessed how effective the models were in discriminating between hypertensive and norniotensive subjects. The evaluation for goodness-of-fit was prompted because methods used in model building are based on relative comparisons of two fitted models, not on absolute comparisons of the probabilities predicted by a model with the observed outcomes. To detect lack-of-fit, we calculated the x 2 statistic of Hosmer and Lemeshow (* 2 HL) 17 by partitioning the distribution of predicted probabilities into "deciles of risk" and summing the difference between the observed proportion of hypertensive subjects and the average predicted probability for subjects in each decile. 18 When computed in this way, the X 2 HL statistic has eight degrees of freedom; thus, at the p<0.05 level of significance, * 2 HL values greater than 15.51 indicate lack-of-fit.
After a model passed the test for goodness-of-fit, we examined how effective it was in discriminating between normotensive and hypertensive subjects. We calculated Somer's D^ statistic as an index of the rank correlation between the predicted and observed outcomes. 19 This statistic, which is computed for all pairs of subjects having different values of the outcome variable, takes on the value 1 when the ranks of the observed outcomes are concordant with the ranks of the predicted probabilities for all such pairs, and it takes on the value 0 when the ranks are concordant for only one-half of the pairs. A value of 1 indicates no overlap in the distributions of predicted probabilities between normotensive and hypertensive subjects and thus perfect ability of the model to discriminate between the different outcomes. Since none of the models achieved this ideal, we also calculated the percentage of interindrvidual variation in predicted probabilities attributable to diagnostic classification (R 2 xl00%) to provide a quantitative measure of variation between versus variation within diagnostic categories. Finally, we plotted the distribution of predicted probabilities to display the extent of overlap in predicted probabilities between hypertensive and normotensive subjects.
Results
Description of the Sample
Most quantitative traits, age being one exception, differed in their distributions between men and women (Table 1) . Means for height, weight, body mass index, waist-to-hip ratio, diastolic blood pressure, and sodiumlithium countertransport were significantly greater in men than in women; means for plasma total cholesterol, HDL cholesterol, apolipoproteins AI, All, and CIII, and pulse rate were significantly less in men than in women. Variances of waist-to-hip ratio, plasma apolipoprotein All, and sodium-lithium countertransport were significantly greater in men than in women; variances of body mass index and plasma apolipoprotein B were significantly less in men than in women.
Of the two categorical traits, blood pressure diagnostic category did not differ in its distribution between men and women but cigarette smoking did. Eightyseven of the 172 men and 140 of the 252 women were hypertensive (51% of men, 56% of women; /?=0.313); the remaining 85 men and 112 women were normotensive. The percentages of men and women who were current smokers were similar (19% of men, 16% of women; p=0.375), but the percentages of those who were former smokers (51% of men, 15% of women) and who had never smoked (30% of men, 69% of women) differed significantly between men and women The model \ 2 (compared with the intercept-only model) was 2030 in men (p<0.001) and 16.69 in women (p<0.001). The odds ratios correspond to 1 and 2 standard deviation (SD) increments in sodium-lithium countertransport above its mean value.
Predictors of Hypertension
Sodium-lithium countertransport alone. When sodiumlithium countertransport was the only predictor trait in a logistic regression model (Table 2) , it made a statistically significant contribution to predicting the probability of having hypertension both in men (model * Inclusion of an additional term representing secondorder effects of sodium-lithium countertransport did not improve prediction in either gender. Positive signs of the logistic regression coefficients indicated that the predicted probability of having hypertension increased in both genders as the level of sodium-lithium countertransport increased. Based on these models, which did not consider the effects of other predictor traits, each standard deviation increase in sodium-lithium countertransport above its mean value, that is, each increase of 0.129 mmol/1 red blood cells (RBC) per hour in men and 0.108 mmol/1 RBC per hour in women, increased the expected odds of having hypertension 2.25 times in men (95% confidence interval [CI], 1.44-3.51) and 1.77 times in women (95% CI, 132-2.37).
Other predictor traits. When sodium-lithium countertransport was not considered, forward stepwise selection identified the following traits as statistically significant predictors of the probability of having hypertension (Table 3) (p=0.039) . Thus, when sodium-lithium countertransport was not considered, the best set of other predictors included age, body mass index, apolipoprotein CII, and apolipoprotein CII squared in men and age, body mass index, apolipoproteins CII and AI, and apolipoprotein CII squared in women.
Signs of the partial logistic regression coefficients for age, body mass index, and apolipoprotein AI (in women) were positive; consequently, the predicted probability of having hypertension increased progressively across the ranges of these predictors. In contrast, because signs of the coefficients for first-and second-order apolipoprotein CII were opposite of each other, the predicted probability of having hypertension either increased or decreased depending on the interval of apolipoprotein CII values considered. Moreover, because the coefficient for first-order apolipoprotein CII was positive in men but negative in women and, conversely, the coefficient for second-order apolipoprotein CII was negative in men but positive in women, the relation between the logarithm of the odds of having hypertension and apolipoprotein CII was concave downward in men but concave upward in women (plots not shown). Nevertheless, when the mean was chosen as a reference value, 1 and 2 SD unit increases in apolipoprotein CII were associated with net increases in the probability of having hypertension in both genders, as indicated by the conditional odds ratios greater than 1.0 in Table 3 .
Sodium-lithium countertransport after other predictor traits. When sodium-lithium countertransport was added to the models that included the best set of other predictors, it improved prediction of the probability of having hypertension in both genders ( Although the partial logistic regression coefficients for sodium-lithium countertransport were lower in these models than in the models (see Table 2 ) that did not include the other predictors (5.59 versus 6.27 in men; 3.64 versus 5.28 in women), the probability of having hypertension still increased in both genders as the level of sodium-lithium countertransport increased (Figure 1) . Based on the partial logistic regression coefficients estimated for sodium-lithium countertransport in these complete models, when the other predictors remained at their mean values, each standard deviation increase in sodium-lithium countertransport still increased the expected odds of having hypertension 2.06 times in men (95% CI, 1.31-3.22) and 1.48 times in women (95% CI, 1.04-2.21).
Based on the set of partial logistic regression coefficients estimated in these complete models, we compared among predictors the conditional odds ratios for 1 and 2 SD unit increases in each predictor above its mean value, assuming that the other predictors remained constant at their mean values (Table 4) . (Standard deviations for each predictor are presented in Table 1 .) In men, the conditional odds ratio for a 1 SD increase in sodiumlithium countertransport was slightly less than that for a 1 SD increase in age (2.24) but greater than that for a 1 Table 4 ). RBC, red blood cells. , and apolipoprotein AI in women (see Table 3 ).
MEN
. Line graphs show predicted probability of having hypertension as a function of sodium-lithium countertransport level in 172 men (panel A) and 252 women (panel B). Plots are based on the partial logistic regression coefficients for sodium-lithium countertransport in models that included age, body weight, apolipoprotein CII, and apolipoprotein AI (in women only) as other predictor traits. Conditional odds ratios associated with standard deviation (SD) increases in sodium-lithium countertransport above its mean are superimposed (see
SD unit increase in body mass index (1.70) or apolipoprotein CII (1.65). In women, the conditional odds ratio for a 1 SD unit increase in sodium-lithium countertransport was less than that for a 1 SD increase in age (3.06), body mass index (2.24), or apolipoprotein CII (1.74) but slightly greater than that for a 1 SD increase in apolipoprotein AI (1.43). In each gender, the rank order of the conditional odds ratios for 2 SD increases in the predictors was the same as for 1 SD increases (Table 4) .
Goodness-of-Fit and Discriminatory Ability of Models
Nonsignificant values of the \ 2 HL statistics suggested that the models presented in Tables 2, 3 , and 4 fit the observed outcomes acceptably well. Even so, the Somer's Dy, and R 2 xl00% statistics indicated that the models differed in their abilities to discriminate between hypertensive and normotensive subjects and that none of the models did a perfect job. When judged by the Somer's D^ statistics, the model that included sodium-lithium countertransport as the only predictor was least effective in separating hypertensive and normotensive subjects (Dyj, 0.360 in men; 0.323 in women). The model that included the other predictor traits did considerably better (D^, 0.516 in men; 0.644 in women), and by a small margin, the model that included the other predictors plus sodium-lithium countertransport was most effective (D^, 0.581 in men; 0.662 in women). The R 2 xl00% statistics also indicated that discriminatory ability increased progressively as the number of predictors in the model increased. Yet, under each model, most interindrvidual variation in the assigned probabilities was due to differences within, not between, diagnostic categories. Even under the best-performing model, only 26% of interindividual variation in the predicted probabilities in men and 33% in women was attributable to differences between diagnostic categories (Table 5 ). This preponderance of within-over between-category differences reflected complete overlap in the range of predicted probabilities between normotensive and hypertensive subjects (Figure 2 ).
Discussion
This cross-sectional study demonstrates that the quantitative level of sodium-lithium countertransport makes a contribution to predicting the probability of having hypertension in a general Caucasian population and that it does so after effects of other traits related to hypertension have been considered. These conclusions are based on analysis of the logistic regression relation between sodium-lithium countertransport and the prevalence of hypertension among adults aged 47-89 years Table 4 ). who are representative of the population of Rochester, Minn.
Sodium-lithium countertransport was statistically significantly correlated with body mass index (r=0.211 in men, ^=0.005; r=0.309 in women, p<0.001) and with apolipoprotein CII (r=0.328 in men,p<0.001; r=0.254 in women, p<0.001) but not with age (r=0.137 in men, /?=0.073; r=0.034 in women, p=0.596) or with apolipoprotein AI (r=0.047 in women, p=0.542). The correlations of sodium-lithium countertransport with body mass index and with apolipoprotein CII probably account for the reductions in the logistic regression coefficients for sodium-lithium countertransport when the other predictor traits were included in the models (compare Tables 2 and 4 ) and for changes in the partial logistic regression coefficients for body mass index and apolipoprotein CII when sodium-lithium countertransport was added to the models that included the other predictors (compare Tables 3 and 4 ). Because the partial logistic regression coefficients for age and apolipoprotein AI (in women) did not change appreciably when sodium-lithium countertransport was added to the latter models, we conclude that the predictive information provided by sodium-lithium countertransport is independent of information contributed by age and apolipoprotein AI. In those samples in which plasma lipids were also measured, increasing triglycerides and HDL cholesterol also contributed to the prediction of elevated blood pressure.
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- 21 Apolipoproteins CII and AI are involved in plasma transport of triglycerides and HDL cholesterol. Statistical correlations are strongly positive between plasma apolipoprotein CII and trigh/ceride concentrations (unpublished observation from our laboratory) and between plasma apolipoprotein AI and HDL cholesterol concentrations. 24 Thus, our finding that plasma concentrations of apolipoproteins CII and AI are related to the probability of having hypertension is not unexpected.
The basis of the statistical association of hypertension with measures of age, body size, lipid metabolism, and cellular cation transport is unknown. However, observational and experimental studies suggest that resistance to insulin-stimulated glucose uptake, primarily localized to skeletal muscle, may play a role. 23 - 26 The mechanisms are not understood, but advanced age and obesity are recognized causes of insulin resistance, 27 and insulin resistance is associated with hypertriglyceridemia 25 and increased sodium-lithium countertransport. 28 It has been hypothesized that chronic hyperinsulinemia, required to compensate for impaired glucose uptake by insulin-resistant tissues, promotes hypertension through its exaggerated effects on insulin-sensitive tissues. These effects may include activation of the sympathetic nervous system, alteration of cellular cation transport, impairment of renal sodium excretion, and stimulation of vascular smooth muscle growth. 25 " 27 Unfortunately, we did not assess measures of insulin resistance in the present study. In future studies, we plan to address the extent to which the traits identified as predictors in this sample contribute to predicting the probability of having hypertension once measures of insulin resistance have been considered. Ideally, one benefit of fitting the logistic regression models that included sodium-lithium countertransport and the other predictor traits would be a determination of the impact of each trait on the probability of having hypertension. Because the predictors are measured on different scales, such determinations are usually made by comparing "standardized" partial regression coefficients, 29 calculated by multiplying each coefficient by the standard deviation of the corresponding predictor trait. The caveats discussed by Greenland and colleagues 30 apply to our comparisons of the odds ratios estimated by exponentiating the standardized partial logistic regression coefficients of each predictor trait (Table 4) . First, the assumption must be made that standard deviation units are comparable measures of variation despite the different scales on which the predictors are measured. Second, because body mass index, plasma apolipoprotein CII, and sodium-lithium countertransport are correlated, and it is not possible to vary one trait without changing the others, estimates of the effects of variation in any single predictor are only hypothetical. Third, because the models included a second-order term for apolipoprotein CII, and therefore, the relation between the logarithm of the odds of having hypertension and apolipoprotein CII was nonlinear, the odds ratios associated with standard deviation increases in apolipoprotein CII would change if a reference value other than the mean value were selected. And fourth, because the odds ratios in Table 4 depend in part on the standard deviations of the predictor traits, their magnitudes and rank order may differ from those in another sample with different distributions of the predictors. Because of these caveats, our comparison of the odds ratios in Table 4 can only suggest that the impact of interindividual variation in sodium-lithium countertransport is intermediate among the effects of variation in the other predictor traits. Another guarded interpretation is that the predictive usefulness of information provided by each of the traits is comparable.
Because most of the traits considered as predictors differed in their distributions between the genders (Table 1) , we modeled their association with the probability of having hypertension separately in men and women. Although age, body mass index, and plasma apolipoprotein CII were predictors in both genders, plasma apolipoprotein AI was an additional predictor in women but not in men (Table 3) . Although plasma apolipoprotein CII was a predictor in both genders, its relation with the logarithm of the odds of having hypertension was different in men (concave downward) and women (concave upward). That the partial logistic regression coefficients estimated for sodium-lithium countertransport and the conditional odds ratios calculated by exponentiating the standardized coefficients (Table 4) were greater in men than in women ( Table 4 ) might suggest that sodium-lithium countertransport makes a greater contribution to prediction in men than in women. However, because the variance of sodium-lithium countertransport was greater in men than in women (Table 1) , and the set of other predictors was not identical in the two genders (Table 3) , such an inference is inappropriate. We can conclude only that the probability of having hypertension increases in both genders as the level of sodium-lithium countertransport increases. Nevertheless, other indications of gender specificity in the relation of hypertension to its predictors probably reflect biological differences between men and women that contribute to differences in the age of onset, severity, and complications of hypertension.
Although the logistic regression models in Tables 2,3 , and 4 fit the data reasonably well, they differed in their ability to discriminate between hypertensive and normotensive subjects. Not surprisingly, discriminatory ability increased as more predictors were included in the models. Still, under even the best performing model, the predicted probabilities overlapped completely between the two diagnostic categories, although they were on the average higher in hypertensive than in normotensive subjects (Figure 2 ). Clearly, additional factors not reflected in sodium-lithium countertransport or the other predictor traits must be involved in determining whether an individual is hypertensive or normotensive. Because interindividual variation in each of these quantitative traits is determined by variation in many genetic and environmental factors, it is unlikely that variation in any single gene or environmental factor, or in any small subset of these factors, will account for a large fraction of the cases of hypertension in the population at large.
To our knowledge, a study of 2,748 residents of Gubbio, Italy, provides the only other analysis of the logistic regression relation between sodium-lithium countertransport and the probability of having hypertension in a general Caucasian population. 13 As the level of sodium-lithium countertransport increased in that sample, so too did the prevalence of hypertension. In logistic regression models, sodium-lithium countertransport made a statistically significant contribution to predicting the probability of having hypertension after the effects of gender, age, body size, and other traits identified as predictors were considered. The set of other predictors only partially overlapped the set we considered (Table 4) . Moreover, subjects in the Gubbio sample were younger than subjects in our sample (mean age, 50 versus 68 years) and they had a lower prevalence of hypertension (38% versus 54%). Because of these differences between the studies, comparison of the partial logistic regression coefficients estimated for sodium-lithium countertransport is not appropriate. Nevertheless, within the Gubbio study, comparison of the odds ratios calculated for standard deviation increases in each predictor trait suggests that the impact of variation in sodium-lithium countertransport on the probability of having hypertension was intermediate in magnitude among the effects of the other predictors. Thus, results from the Gubbio study reinforce our conclusion that sodium-lithium countertransport provides information that is helpful in predicting the probability of having hypertension and is not provided by other traits related to hypertension.
Because the present study and the Gubbio study are cross-sectional, they cannot exclude the possibility that increases in sodium-lithium countertransport that occur after the diagnosis of hypertension, but are not present before it, account for the apparent relation with hypertension. However, several observations from previous studies argue against this possibility. First, if sodiumlithium countertransport increased as a result of elevated blood pressure or drug treatment of hypertension, its mean level or variance would be expected to increase with age as do the mean levels of blood pressure, the prevalence of hypertension, and the frequency of use of antihypertensive medications. On the contrary, the mean level and variance of sodium-lithium countertransport remain nearly constant from ages 5 to 89 years in the general population. 8 Second, the mean level of sodium-lithium countertransport is increased before the diagnosis or treatment of hypertension in some subjects with borderline elevated blood pressure 13 and in the young normotensive offspring of hypertensive parents. 7 Third, the mean level of sodium-lithium countertransport is similar in hypertensive subjects regardless of whether they are treated with antihypertensive medications. 13 Notwithstanding these arguments, longitudinal follow-up of normotensive cohorts will be required to validate the hypothesis that sodium-lithium countertransport predicts the risk for the development of hypertension.
In pursuit of this objective, Hunt and colleagues 31 assessed the incidence of hypertension among 974 initially normotensive adults who were members of 98 multigeneration pedigrees in Utah. In 342 members of 17 pedigrees, segregation of alleles at a biometrically inferred gene explained a large increment in sodiumlithium countertransport level. In those family members likely to have the single locus genotype associated with increased sodium-lithium countertransport, the incidence of hypertension was 4.6 times greater than in individuals likely to have alternative genotypes (hypertension incidence, 18.8% versus 3.7%). However, in the overall sample, the incidence of hypertension was not related to the quantitative level of sodium-lithium countertransport. Thus, the investigators concluded that risk for the development of hypertension is increased only in persons having a particular gene associated with increased sodium-lithium countertransport and is not increased in persons with elevated sodium-lithium countertransport caused by other genetic or environmental factors. Because the Utah sample was composed of family members at high risk for the development of stroke, myocardial infarction, or hypertension, extension of inferences to other populations must be cautious. Follow-up of more broadly representative samples, such as those in Rochester and Gubbio, will be necessary to establish whether sodium-lithium countertransport level (or genotype) predicts the risk for the development of hypertension in the general Caucasian population.
In conclusion, the present cross-sectional study demonstrates that the quantitative level of sodium-lithium countertransport makes a contribution to predicting the probability of having hypertension in a general Caucasian population and that it does so after age and measures of obesity and hyperlipidemia have been considered. The contribution of sodium-lithium countertransport to prediction is estimated to be comparable to that made by other established predictors of hypertension. Among the biological traits that have been consistently related to hypertension in samples from the general population, sodium-lithium countertransport is presently the only one that appears to be influenced by a large effect of variation in a single gene. 9 -11 Although our results suggest that no one trait that relates genetic and environmental variation to interindividual differences in the occurrence of hypertension will explain a large fraction of cases of hypertension in the general population, further studies of sodium-lithium countertransport hold the promise of leading us to one of the genetic loci associated with predisposition for the development of essential hypertension. S T Turner, T R Rebbeck and C F Sing years old. Sodium-lithium countertransport and probability of hypertension in Caucasians 47 to 89
